Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study


To validate the correlation between ANXA3 expression and prognosis in breast cancer, a retrospective study encompassing 309 breast cancer patients was performed. The expression of ANXA3 was determined by the immunohistochemical examination of tissue sections by the Max Vision™ method. The ANXA3 levels in the patient samples were validated for the prognosis… (More)
DOI: 10.1155/2017/2603685


6 Figures and Tables